Treatment Patterns, Clinical Outcomes and Healthcare Costs of Advanced Non-Small Cell Lung Cancer: A Real-World Evaluation in Italy

by Matteo Franchi, Diego Cortinovis, Giovanni Corrao
Published 2021-07-01

Cost-Consequence Analysis of Three Different Diagnostic Strategies in the First- and Second-Line Treatment of Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

by Giovanni Gancitano, Roberto Ravasio, Matteo Dionisi, Diego Cortinovis
Published 2018-05-01

Clinical Impact of two Different Diagnostic Strategies in the First- and Second-Line Treatment of Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer

by Giovanni Gancitano, Roberto Ravasio, Lorenzo Cattelino, Paolo Di Procolo, Diego Cortinovis
Published 2020-02-01

Targeted Therapies in Early Stage NSCLC: Hype or Hope?

by Alex Friedlaender, Alfredo Addeo, Alessandro Russo, Vanesa Gregorc, Diego Cortinovis, Christian D. Rolfo
Published 2020-08-01

Novel Cytotoxic Chemotherapies in Small Cell Lung Carcinoma

by Diego Cortinovis, Paolo Bidoli, Stefania Canova, Francesca Colonese, Maria Gemelli, Maria Luisa Lavitrano, Giuseppe Luigi Banna, Stephen V. Liu, Alessandro Morabito
Published 2021-03-01

The Reproducibility of the Immunohistochemical PD-L1 Testing in Non-Small-Cell Lung Cancer: A Multicentric Italian Experience

by Elena Vigliar, Umberto Malapelle, Francesca Bono, Nicola Fusco, Diego Cortinovis, Emanuele Valtorta, Alexiadis Spyridon, Manuela Bimbatti, Mario Zocchi, Chiara Piva, Gabriella Gaudioso, Antonino Iaccarino, Patrizia Morbini, Fabio Pagni
Published 2019-01-01

Metabolic Parameters as Biomarkers of Response to Immunotherapy and Prognosis in Non-Small Cell Lung Cancer (NSCLC): A Real World Experience

by Lavinia Monaco, Maria Gemelli, Irene Gotuzzo, Matteo Bauckneht, Cinzia Crivellaro, Carlo Genova, Diego Cortinovis, Lodovica Zullo, Luca Carlofrancesco Ammoni, Davide Paolo Bernasconi, Giovanni Rossi, Silvia Morbelli, Luca Guerra
Published 2021-04-01

Vitamin D Supplementation and Cancer Mortality: Narrative Review of Observational Studies and Clinical Trials

by Patrizia Gnagnarella, Valeria Muzio, Saverio Caini, Sara Raimondi, Chiara Martinoli, Susanna Chiocca, Claudia Miccolo, Paolo Bossi, Diego Cortinovis, Ferdinando Chiaradonna, Roberta Palorini, Federica Facciotti, Federica Bellerba, Stefania Canova, Sara Gandini
Published 2021-09-01

p65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma

by Federica Giordano, Valentina Vaira, Diego Cortinovis, Sara Bonomo, Joyce Goedmakers, Federica Brena, Annamaria Cialdella, Leonarda Ianzano, Irene Forno, Maria Grazia Cerrito, Roberto Giovannoni, Gian Luca Ferri, Ennio Tasciotti, Silve Vicent, Francesco Damarco, Silvano Bosari, Marialuisa Lavitrano, Emanuela Grassilli
Published 2019-06-01

High Prevalence and Early Occurrence of Skeletal Complications in EGFR Mutated NSCLC Patients With Bone Metastases

by Marta Laganà, Cristina Gurizzan, Elisa Roca, Diego Cortinovis, Diego Signorelli, Filippo Pagani, Anna Bettini, Lucia Bonomi, Silvia Rinaldi, Rossana Berardi, Marco Filetti, Raffaele Giusti, Sara Pilotto, Michele Milella, Salvatore Intagliata, Alice Baggi, Alessio Cortellini, Hector Soto Parra, Matteo Brighenti, Fausto Petrelli, Chiara Bennati, Paolo Bidoli, Marina Chiara Garassino, Alfredo Berruti
Published 2020-11-01